Efficacy and Safety of Natamycin and Lactulose Vaginal Suppositories in Treatment of Vulvovaginal Candidiasis

NCT06411314 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

218

Enrollment

INDUSTRY

Sponsor class

Conditions

Vulvovaginal Candidiasis, Genital

Interventions

COMBINATION_PRODUCT: Natamycin + Lactulose 100 mg + 300 mg vaginal suppositories
DRUG: Lactulose 300 mg vaginal suppositories
DRUG: Pimafucin® (natamycin) 100 mg vaginal suppositories

Sponsor

Avva Rus, JSC